PMC:7650537 / 15522-15703 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T108","span":{"begin":104,"end":107},"obj":"Body_part"}],"attributes":[{"id":"A108","pred":"fma_id","subj":"T108","obj":"http://purl.org/sig/ont/fma/fma62872"}],"text":"Twenty-four (92.3%) of the 26 SARS-CoV-2 infected patients were reactive in one or both versions of the IgG recomLine assay; the test results differed only in three sera (Figure 1)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T78","span":{"begin":30,"end":38},"obj":"Disease"}],"attributes":[{"id":"A78","pred":"mondo_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Twenty-four (92.3%) of the 26 SARS-CoV-2 infected patients were reactive in one or both versions of the IgG recomLine assay; the test results differed only in three sera (Figure 1)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T140","span":{"begin":129,"end":133},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Twenty-four (92.3%) of the 26 SARS-CoV-2 infected patients were reactive in one or both versions of the IgG recomLine assay; the test results differed only in three sera (Figure 1)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T123","span":{"begin":0,"end":181},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Twenty-four (92.3%) of the 26 SARS-CoV-2 infected patients were reactive in one or both versions of the IgG recomLine assay; the test results differed only in three sera (Figure 1)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"287","span":{"begin":50,"end":58},"obj":"Species"},{"id":"291","span":{"begin":30,"end":49},"obj":"Disease"}],"attributes":[{"id":"A287","pred":"tao:has_database_id","subj":"287","obj":"Tax:9606"},{"id":"A291","pred":"tao:has_database_id","subj":"291","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Twenty-four (92.3%) of the 26 SARS-CoV-2 infected patients were reactive in one or both versions of the IgG recomLine assay; the test results differed only in three sera (Figure 1)."}